Federal prosecutors have charged U.K. drugmaker Indivior with orchestrating a fraud scheme to boost prescriptions of its opioid-addiction treatment Suboxone Film, the U.S. Justice Department announced April 9.
Indivior allegedly misled healthcare providers and insurers into thinking that Suboxone Film was safer and harder to abuse than other opioid-addiction treatments. The company also sought to boost profits by using a "Here to Help" telephone and internet program that linked opioid-dependent patients to physicians who prescribed opioids at high rates, prosecutors charged.
By engaging in these behaviors, the drugmaker obtained billions of dollars in fraudulent revenue, the U.S. charges.
Indivior has denied the charges.